Published in Medical Letter on the CDC and FDA, November 15th, 2009
"CYANOKIT® is well-suited to King's existing line of acute care products," said Brian A. Markison, Chairman, President and CEO. "Our portfolio of antidotes currently serves the emergency medical services community, as well as the U.S. Department of Defense and other federal, state...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA